Qilu Pharmaceutical Group

Jinan, China Founded: 1958 • Age: 68 yrs
APIs and intermediates are developed and manufactured for pharmaceuticals.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Qilu Pharmaceutical Group

Qilu Pharmaceutical Group is a company based in Jinan (China) founded in 1958 by Xiayang Qiu. Qilu Pharmaceutical Group operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

  • Headquarter Jinan, China
  • Founders Xiayang Qiu
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Qilu Pharmaceutical Group

Premium access

Detailed funding history for Qilu Pharmaceutical Group

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Qilu Pharmaceutical Group

Investments
Premium access

Investment portfolio details for Qilu Pharmaceutical Group

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Qilu Pharmaceutical Group

Premium access

Detailed financials for Qilu Pharmaceutical Group

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Qilu Pharmaceutical Group Comparisons

Qilu Pharmaceutical Group Primary company
Description
APIs and intermediates are developed and manufactured for ph...
Location
Jinan, China
Founded Year
1958
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Qilu Pharmaceutical Group

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Qilu Pharmaceutical Group

Qilu Pharmaceutical Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical and biotechnology company
Locked Locked Locked
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
Locked Locked Locked
APIs and drug products are developed and valorized in pharmaceuticals.
Locked Locked Locked
APIs, intermediates, and biochemical reagents are developed and manufactured.
Locked Locked Locked
APIs are developed and manufactured for therapeutic areas.
Locked Locked Locked
Contract development, manufacturing, and analytical services for APIs are offered.
Premium access

Detailed competitors of Qilu Pharmaceutical Group

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Qilu Pharmaceutical Group

Premium access

Complete news archive for Qilu Pharmaceutical Group

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Qilu Pharmaceutical Group

Qilu Pharmaceutical Group was founded in 1958.

Qilu Pharmaceutical Group is headquartered in Jinan, China. It is registered at Jinan, Shandong, China.

Xiayang Qiu is the current CEO of Qilu Pharmaceutical Group. They have also founded this company.

Founded in 1958 and based in Jinan, China, Qilu Pharmaceutical Group focuses on the development and production of active pharmaceutical ingredients and intermediates, including both sterile and non-sterile forms. Therapeutic areas addressed include oncology, cardiovascular, cerebrovascular, anti-infective, psychiatric, and ophthalmic conditions. Products are exported to regions such as Australia, North America, Japan, and the United Kingdom.

Qilu Pharmaceutical Group's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available